Latest & greatest articles for pregnancy

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on pregnancy or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on pregnancy and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for pregnancy

21. Pregabalin (Lyrica or other brands) and gabapentin (Neurontin or other brands): known dangers and uncertainties during pregnancy

this risk. In practice, pregabalin and gabapentin should be avoided whenever possible in women who are or could become pregnant. However, when either of these drugs is chosen during pregnancy, it is important to inform the woman of its known risks and uncertainties. If used close to delivery, it is useful to inform the delivery team so that the neonate receives the necessary monitoring. ©Prescrire 1 May 2020 Share Share Download the full review. Antiepileptics and pregnancy: potential long-term effects (...) Pregabalin (Lyrica or other brands) and gabapentin (Neurontin or other brands): known dangers and uncertainties during pregnancy Prescrire IN ENGLISH - Spotlight ''Pregabalin (Lyrica° or other brands) and gabapentin (Neurontin° or other brands): known dangers and uncertainties during pregnancy'', 1 May 2020 {1} {1} {1} | | > > > Pregabalin (Lyrica° or other brands) and gabapentin (Neurontin° or other brands): known dangers and uncertainties during pregnancy Spotlight Every month, the subjects

2020 Prescrire

22. Cesarean scar pregnancy

Cesarean scar pregnancy Society for Maternal-Fetal Medicine (SMFM) Consult Series #49: Cesarean scar pregnancy - American Journal of Obstetrics & Gynecology Go search , PB2-B14, May 01, 2020 Powered By Mendeley Share on Society for Maternal-Fetal Medicine (SMFM) Consult Series #49: Cesarean scar pregnancy Society for Maternal-Fetal Medicine (SMFM)pubs@smfm.org ∗ Russell Miller Affiliations The American College of Obstetricians and Gynecologists (ACOG), the American Institute of Ultrasound (...) this document Published: January 20, 2020 DOI: Cesarean scar pregnancy is a complication in which an early pregnancy implants in the scar from a prior cesarean delivery. This condition presents a substantial risk for severe maternal morbidity because of challenges in securing a prompt diagnosis, as well as uncertainty regarding optimal treatment once identified. Ultrasound is the primary imaging modality for cesarean scar pregnancy diagnosis, although a correct and timely determination can be difficult

2020 Society for Maternal-Fetal Medicine

23. Coronavirus (COVID-19) infection and pregnancy

Coronavirus (COVID-19) infection and pregnancy 1 Information for healthcare professionals Version 9: Published Wednesday 13 May 2020 Coronavirus (COVID-19) Infection in Pregnancy2 Contents Summary of updates 3-5 1. Introduction 6-11 2. Advice for health professionals to share with pregnant women 12-19 3. Advice for all midwifery and obstetric services caring for pregnant women 20-36 4. Advice for services caring for women with suspected or confirmed COVID-19 37-39 Acknowledgements 40 Appendix 1 (...) for antibiotics at presentation, with early review and rationalisation of antibiotics if COVID-19 is confirmed.’ 9 13.5.20 3.6: Statement added: ‘A woman with moderate or severe COVID symptoms who happens to be pregnant but with no immediate pregnancy issue should be cared for by the same multidisciplinary team as a non-pregnant woman with additional input from the maternity team. The labour ward should not be the default location for all pregnant women.’6 1. Introduction7 1. Introduction The following advice

2020 Royal College of Obstetricians and Gynaecologists

24. The cost-effectiveness of progesterone in preventing miscarriages in women with early pregnancy bleeding: an economic evaluation based on the PRISM trial Full Text available with Trip Pro

):CD003511. doi: 10.1002/14651858.CD003511.pub3. Cochrane Database Syst Rev. 2013. PMID: 24173668 Updated. Review. Show more similar articles References Wilcox AJ. Fertility and Pregnancy: An Epidemiologic Perspective. Oxford: Oxford University Press; 2010. Wilson R, Jenkins C, Miller H, McInnes IB, Moore J, McLean MA, et al. Abnormal cytokine levels in non‐pregnant women with a history of recurrent miscarriage. Eur J Obstet Gynecol Reprod Biol 2004;115:51–4. - Jurkovic D, Overton C, Bender‐Atik R (...) The cost-effectiveness of progesterone in preventing miscarriages in women with early pregnancy bleeding: an economic evaluation based on the PRISM trial The Cost-Effectiveness of Progesterone in Preventing Miscarriages in Women With Early Pregnancy Bleeding: An Economic Evaluation Based on the PRISM Trial - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features

2020 EvidenceUpdates

25. Coronavirus disease 2019 (COVID-19) and pregnancy: a systematic review

Coronavirus disease 2019 (COVID-19) and pregnancy: a systematic review Coronavirus Disease 2019 (COVID-19) and Pregnancy: A Systematic Review - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. National Institutes of Health National Library of Medicine National Center for Biotechnology Information Show account info Close Account Logged (...) . Online ahead of print. Coronavirus Disease 2019 (COVID-19) and Pregnancy: A Systematic Review , , , Affiliations Expand Affiliations 1 Department of Obstetrics, Chengdu Jinjiang Maternity and Child Health Hospital, Chengdu, China. 2 The First Clinical College of Chongqing Medical University, Chongqing, China. 3 North Sichuan Medical College, Nanchong, China. PMID: 32354293 DOI: Item in Clipboard Coronavirus Disease 2019 (COVID-19) and Pregnancy: A Systematic Review Ziyi Yang et al. J Matern Fetal

2020 EvidenceUpdates

26. ASCIA Guidelines - Acute management of anaphylaxis in pregnancy

the pregnant and non-pregnant population. A dose of 0.5mg adrenaline intramuscularly (IM) can be given for treatment of anaphylaxis in pregnancy. Anaphylaxis definitions Any acute onset illness with typical skin features (urticarial rash or erythema/flushing, and/or angioedema), PLUS involvement of respiratory and/or cardiovascular and/or persistent severe gastrointestinal symptoms; or Any acute onset of hypotension or bronchospasm or upper airway obstruction where anaphylaxis is considered possible, even (...) ASCIA Guidelines - Acute management of anaphylaxis in pregnancy ASCIA Guidelines Acute Management of Anaphylaxis in Pregnancy - Australasian Society of Clinical Immunology and Allergy (ASCIA) | | ASCIA Guidelines Acute Management of Anaphylaxis in Pregnancy There are limited studies exploring the management of patients with anaphylaxis and in particular anaphylaxis in pregnancy. These guidelines are intended for medical practitioners, midwives and nurses providing first responder emergency care

2020 Australasian Society of Clinical Immunology and Allergy

27. Screening for Bacterial Vaginosis in Pregnant Persons to Prevent Preterm Delivery: US Preventive Services Task Force Recommendation Statement. Full Text available with Trip Pro

Screening for Bacterial Vaginosis in Pregnant Persons to Prevent Preterm Delivery: US Preventive Services Task Force Recommendation Statement. Bacterial vaginosis is common and is caused by a disruption of the microbiological environment in the lower genital tract. In the US, reported prevalence of bacterial vaginosis among pregnant women ranges from 5.8% to 19.3% and is higher in some races/ethnicities. Bacterial vaginosis during pregnancy has been associated with adverse obstetrical outcomes (...) including preterm delivery, early miscarriage, postpartum endometritis, and low birth weight.To update its 2008 recommendation, the USPSTF commissioned a review of the evidence on the accuracy of screening and the benefits and harms of screening for and treatment of bacterial vaginosis in asymptomatic pregnant persons to prevent preterm delivery.This recommendation applies to pregnant persons without symptoms of bacterial vaginosis.The USPSTF concludes with moderate certainty that screening

2020 JAMA

28. Updated advice regarding PPE to be worn when managing pregnant women with known or suspected COVID-19

Updated advice regarding PPE to be worn when managing pregnant women with known or suspected COVID-19 PPE Jargon Buster FRSM fluid resistant surgical mask FRDG fluid resistant disposable gown PPE personal protective equipment AGP aerosol generating procedure FFP mask filtering face piece respirator 11 April 2020 | Dr Nuala Lucas, Dr Jim Bamber, Dr Fiona Donald, Dr Felicity Platt | icmanaesthesiacovid-19.orgChoice of PPE for obstetric anaesthetists according to mode of transmission risk Non

2020 ICM Anaesthesia COVID-19

29. Lithium during pregnancy: malformations, fetotoxicity and uncertain long-term effects

 |   |  Spotlight Lithium during pregnancy: malformations, fetotoxicity and uncertain long-term effects FEATURED REVIEW Outside the context of pregnancy, lithium is the standard "mood stabiliser" for the treatment of bipolar disorder. What are the main known short-term and long-term consequences of in utero exposure to lithium? Full review (3 pages) available for download by subscribers. Abstract A meta-analysis of about 600 pregnant women exposed to lithium during the first (...) trimester of pregnancy, from six cohorts, showed that lithium roughly doubled the risk of major malformations. Another study in about 700 pregnant women with first-trimester exposure showed that doses of lithium above 600 mg per day increased the risk of congenital heart defects, in particular Ebstein's anomaly. Second- and third-trimester exposure increases the risk of polyhydramnios. Seizures, hypotonia, and heart rate and heart rhythm disorders are foreseeable. Various neonatal complications

2020 Prescrire

30. Water birth and hydrotherapy for pregnant people with suspected or confirmed COVID-19

Water birth and hydrotherapy for pregnant people with suspected or confirmed COVID-19 Water birth and hydrotherapy for pregnant people with suspected or confirmed COVID-19 On March 17, 2020, the Royal College of Obstetricians and Gynecologists (RCOG) updated their guidance on Coronavirus (COVID-19) Infection in Pregnancy to include information for health care providers regarding water birth. This guidance states that “the use of birthing pools in hospital should be avoided in suspected (...) or confirmed cases, given evidence of transmission in faeces and the inability to use adequate protection equipment for healthcare staff during water birth.” (1) The RCOG opinion does not concern the feasibility of water birth for the well pregnant person during the COVID-19 pandemic. Rather, this opinion specifically indicates the use of birthing pools in hospitals should be avoided if the pregnant person has suspected or confirmed COVID-19. Although not explicitly stated, presumably this means

2020 Ontario Midwives

31. Coronavirus (COVID-19) and Pregnancy: What Maternal-Fetal Medicine Subspecialists Need to Know

- guidance.html). What is known about COVID-19 in pregnancy? Currently, there is limited information from published scientific reports about the susceptibility of pregnant women to COVID-19 and severity of infection. Available data are still limited to small case series. In general, pregnant women experience immunologic and physiologic changes that make them more susceptible to viral respiratory infections. The initial characterization of pregnant women as a high-risk group was based largely on this fact (...) potentially lower risk in pregnant women, but these series included a total of only 18 patients and must be interpreted with caution 7, 8 . At present, there is no evidence that pregnancy increases a woman’s risk of acquiring COVID-19 or developing severe symptoms from the disease. Anecdotal experience in the United States indicates that pregnant women are as likely as the general public to develop symptoms if infected with coronavirus; symptoms are likely to be mild to moderate, as is true

2020 Society for Maternal-Fetal Medicine

32. Definitions of infertility and recurrent pregnancy loss: a committee opinion

Definitions of infertility and recurrent pregnancy loss: a committee opinion De?nitions of infertility and recurrent pregnancy loss: a committee opinion Practice Committee of the American Society for Reproductive Medicine American Society for Reproductive Medicine, Birmingham, Alabama Thisdocumentcontainsthede?nitionsofinfertilityandrecurrentpregnancylossasde?nedbythePracticeCommitteeoftheAmericanSo- ciety for Reproductive Medicine. It replaces the document, ‘‘De?nitions of Infertility (...) and Recurrent Pregnancy Loss: a Committee Opinion,’’ last published in 2013 (Fertil Steril 2013;99:63). (Fertil Steril 2020;113:533–5.2019 by American Society for Reproductive Medicine.) El resumen está disponible en Español al?nal del artículo. Discuss: You can discuss this article with its authors and other readers at https://www.fertstertdialog.com/users/16110-fertility- and-sterility/posts/56482-29354 I nfertility is categorized as a disease bytheWorldHealthOrganization,a designationsupportedbynumerous

2020 Society for Assisted Reproductive Technology

33. Bacterial Vaginosis in Pregnant Persons to Prevent Preterm Delivery: Screening

of the Agency for Healthcare Research and Quality or the U.S. Department of Health and Human Services. Collapse All Bacterial vaginosis is common and is caused by a disruption of the microbiological environment in the lower genital tract. In the US, reported prevalence of bacterial vaginosis among pregnant women ranges from 5.8% to 19.3% and is higher in some races/ethnicities. Bacterial vaginosis during pregnancy has been associated with adverse obstetrical outcomes including preterm delivery, early (...) vaginal clindamycin) presented results for preterm delivery at less than 34 weeks, and the results were mixed. Potential Harms The harms of screening for bacterial vaginosis in pregnant persons and treatment with antibiotics generally involve adverse effects such as gastrointestinal upset and vaginal candidiasis. Four observational studies and 2 large meta-analyses of observational studies on the use of metronidazole during pregnancy for any reason (not limited to bacterial vaginosis) reported

2020 U.S. Preventive Services Task Force

34. Covid-19: Recommendations for GDM screening and oral glucose tolerance test (OGTT) during pregnancy and postpartum

Covid-19: Recommendations for GDM screening and oral glucose tolerance test (OGTT) during pregnancy and postpartum Translating evidence into best clinical practice Queensland Health NOTICE OF UPDATE DURING COVID-19 PANDEMIC DATE 14 April 2020 TOPIC Recommendations for GDM screening and oral glucose tolerance test (OGTT) during pregnancy and postpartum APPLIES TO All pregnant and postnatal women irrespective of COVID-19 status RATIONALE During the COVID-19 pandemic • Supports social distancing (...) macrosomia (birth weight > 4500 g or > 90th percentile • Previous perinatal loss • Polycystic ovarian syndrome • Medications (corticosteroids, antipsychotics) • Multiple pregnancy COVID-19 pandemic • Applies to: Pregnant women regardless of COVID-19 status • Rationale: To support social distancing and minimise blood collection time (i.e not based on new evidence) • Implementation: Commence as practical and convenient. Seek expert advice as clinically appropriate Check fasting FBG • At 24–28 weeks

2020 Queensland Health

35. FSRH CEU: information to support management of individuals requesting to discontinue contraception to plan a pregnancy during the Covid-19 outbreak

FSRH CEU: information to support management of individuals requesting to discontinue contraception to plan a pregnancy during the Covid-19 outbreak FSRH CEU: information to support management of individuals requesting to discontinue contraception to plan a pregnancy during the Covid-19 outbreak (26 March 2020) - Faculty of Sexual and Reproductive Healthcare Privacy notice This site makes use of cookies . If you continue we'll assume you are happy to receive them. FSRH CEU: information (...) to support management of individuals requesting to discontinue contraception to plan a pregnancy during the Covid-19 outbreak (26 March 2020) FSRH CEU: information to support management of individuals requesting to discontinue contraception to plan a pregnancy during the Covid-19 outbreak (26 March 2020) Share this article Published on: 26 March 2020 File size: 149kb PDF File type: Covid-19 (Coronavirus) FSRH CEU Individuals planning pregnancy during Covid-19: information to support healthcare

2020 Faculty of Sexual & Reproductive Healthcare

36. Joint Statement: Recent Developments Regarding COVID-19 and Pregnant Women

, the CDC continues to recognize that pregnant women have been at risk for severe illness, morbidity, or mortality compared with the general population in other related coronavirus infections (including severe acute respiratory syndrome coronavirus (SARS-CoV). The CDC’s current guidance regarding COVID-19 and pregnancy is based on limited data, which, at this point, does not indicate that pregnancy alone puts people at higher risk for severe illness resulting from COVID-19 infection. Limited data (...) Joint Statement: Recent Developments Regarding COVID-19 and Pregnant Women Joint Statement: Recent Developments Regarding COVID-19 and Pregnant Women — April 6, 2020 — The American College of Obstetricians and Gynecologists and the Society for Maternal-Fetal Medicine are aware that the Centers for Disease Control and Prevention (CDC) recently removed pregnant people from their webpage that outlines “people who are at higher risk for severe illness” from COVID-19. Consistent with available data

2020 American College of Obstetricians and Gynecologists

37. Physical Activity and Exercise During Pregnancy and the Postpartum Period

activity or who were physically active before pregnancy can continue these activities during pregnancy and the postpartum period. Additionally, women who are pregnant should be under the care of an obstetrician-gynecologist or other obstetric care provider who can monitor the progress of the pregnancy. Women who are pregnant can consult their obstetrician–gynecologist or other obstetric care provider about whether or how to adjust their physical activity during pregnancy and postpartum . Physical (...) . In the absence of obstetric or medical complications or contraindications, physical activity in pregnancy is safe and desirable, and pregnant women should be encouraged to continue or to initiate safe physical activities , . Box 1. Examples of Exercises That Have Been Extensively Studied in Pregnancy and Found to Be Safe and Beneficial Walking Stationary cycling Aerobic exercises Dancing Resistance exercises (eg, using weights, elastic bands) Stretching exercises Hydrotherapy, water aerobics Modified from

2020 American College of Obstetricians and Gynecologists

38. Impact of music therapy before first-trimester instrumental termination of pregnancy: a randomised controlled trial

Impact of music therapy before first-trimester instrumental termination of pregnancy: a randomised controlled trial Impact of Music Therapy Before First-Trimester Instrumental Termination of Pregnancy: A Randomised Controlled Trial - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Welcome to the new PubMed. For legacy PubMed go to . Clipboard, Search History, and several other advanced features are temporarily unavailable (...) Create file Cancel Actions Cite Share Permalink Copy Page navigation BJOG Actions . 2020 May;127(6):738-745. doi: 10.1111/1471-0528.16102. Epub 2020 Feb 14. Impact of Music Therapy Before First-Trimester Instrumental Termination of Pregnancy: A Randomised Controlled Trial , , , , , Affiliations Expand Affiliation 1 Department of Obstetrics and Gynaecology, University Hospital of Angers, Angers, France. PMID: 31957130 DOI: Item in Clipboard Impact of Music Therapy Before First-Trimester Instrumental

2020 EvidenceUpdates

39. Effect of High-Dose vs Standard-Dose Vitamin D Supplementation in Pregnancy on Bone Mineralization in Offspring Until Age 6 Years: A Prespecified Secondary Analysis of a Double-Blinded, Randomized Clinical Trial

mineralization, but investigations are few and with mixed results. Objective: To investigate the effect of a high dose vs standard dose of vitamin D supplementation in pregnancy on anthropometric and bone outcomes until age 6 years in the offspring. Design, setting, and participants: A prespecified analysis of a double-blinded, randomized clinical trial in the Copenhagen Prospective Studies on Asthma in Childhood 2010 mother-child cohort that included 623 pregnant mothers and their 584 children. Data were (...) Effect of High-Dose vs Standard-Dose Vitamin D Supplementation in Pregnancy on Bone Mineralization in Offspring Until Age 6 Years: A Prespecified Secondary Analysis of a Double-Blinded, Randomized Clinical Trial Effect of High-Dose vs Standard-Dose Vitamin D Supplementation in Pregnancy on Bone Mineralization in Offspring Until Age 6 Years: A Prespecified Secondary Analysis of a Double-Blinded, Randomized Clinical Trial - PubMed This site needs JavaScript to work properly. Please enable

2020 EvidenceUpdates

40. Mindfetalness to increase women's awareness of fetal movements and pregnancy outcomes: a cluster-randomised controlled trial including 39 865 women Full Text available with Trip Pro

Mindfetalness to increase women's awareness of fetal movements and pregnancy outcomes: a cluster-randomised controlled trial including 39 865 women Mindfetalness to Increase Women's Awareness of Fetal Movements and Pregnancy Outcomes: A Cluster-Randomised Controlled Trial Including 39 865 Women - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Welcome to the new PubMed. For legacy PubMed go to . Clipboard, Search History (...) Create a file for external citation management software Create file Cancel Actions Cite Share Permalink Copy Page navigation BJOG Actions . 2020 Jan 23. doi: 10.1111/1471-0528.16104. Online ahead of print. Mindfetalness to Increase Women's Awareness of Fetal Movements and Pregnancy Outcomes: A Cluster-Randomised Controlled Trial Including 39 865 Women , , , , , , Affiliations Expand Affiliations 1 Department of Women and Children's Health, Karolinska Institutet, Sophiahemmet University, Stockholm

2020 EvidenceUpdates